Back in December the job layoff numbers were announced: Merck - 8,400 jobs Schering-Plough - 5,500 jobs. This is probably not going to help as far as the number of employed individuals at each company but that takes time to shuffle down. 
From earlier this year, I guess they will be patching up differences…that is if you want to look favorable when the job cuts come along…
Schering-Plough Exec To Merck Exec: ‘F… Off’
Something to think about when composing and sending an email, it could become public at any given time, even viewed by Congress...this relating back to the controversy over the Vitorin venture....which is continuing to surmount...BD
So what does Veltri write back? “Soren is a prick. How’s that for staying calm. Tell him to f… off. Rick.”
Given that the House committee released these documents today, we wonder if Veltri is any calmer now. Kastelein is upset that he had heard nothing about an upcoming ‘consultant meeting’ to review the trial and
plans to write Christiansen’s counterparts at Schering-Plough.
Well one thing for sure, both sides are working towards transparency in one way or another and wonder who will be the next major player the the pharma consolidation business. BD
Merck & Co. agreed to buy rival Schering-Plough Corp. in a $41.1 billion deal that furthers the ailing pharmaceutical industry's consolidation to bigger and more diversified companies.
With the move, Merck is forsaking its traditional reliance on homegrown research and small acquisitions to propel growth. Chief Executive Richard Clark joins a growing number of industry executives who have concluded that drug makers need to diversify in order to weather the economic downturn and the vagaries of drug development.
Merck to Buy Schering-Plough in $41.1 Billion Cash, Stock Deal - WSJ.com
0 comments :
Post a Comment